Pfizer, BioNTech seek US vaccine clearance for ages 5 to 11- latest updates
TRT World says Pfizer Inc and BioNTech SE have asked US regulators to authorise emergency use of their vaccine for children ages 5 to 11, a group for whom no shot is currently allowed, Pfizer said on Thursday.
The US Food and Drug Administration has set a date of October 26 for its panel of outside advisers to meet and discuss the application, making it possible for children in this age group – numbering around 28 million – to begin receiving the two-dose Pfizer/BioNTech vaccine shortly afterward.
“With new cases in children in the US continuing to be at a high level, this submission is an important step in our ongoing effort against #COVID19,” Pfizer wrote on Twitter.
FOLLOW US ON SOCIAL MEDIA AND SHARE WTX NEWS WITH YOUR FRIENDS AND FAMILY:
Facebook – Please like our page
Twitter – Twitter updates available in English and Arabic. Please follow us and we would love to hear from you
Instagram – Follow our pages in English and Arabic